TCL Archive Cancer Advocacy: Deal Returns $3M to Office of Women’s Health, Spends $3.5M On Workshops August 1, 1997
TCL Archive In Brief: NCI Tells Cooperative Groups To Submit applications For Extra Multimodality Funds November 28, 1975
TCL Archive Phase III Xtandi Trial Meets Primary Endpoints Of Progression-Free and Overall Survival November 29, 2013
TCL Archive ODAC Votes Against Cell Therapeutics Agent; Requires ChemGenex To Develop Diagnostic. April 9, 2010